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the presence and size of JBA predicts future ipsilateral
ischemic stroke.
Methods: JBAwas defined as an area of pixels with gray
scale value 25 adjacent to the lumen without a visible
echogenic cap, after image normalization. The size of a JBA
was measured in the carotid plaque images of 1121 patients
with asymptomatic carotid stenosis 50-99% in relation to
the bulb (ACSRS study), followed-up for up to 8 years.
Results: JBA had a linear association with future stroke
rate. The area under the ROC curve was 0.816. Using
Kaplan Meier curves, the mean annual stroke rate was 0.4%
in 706 patients with JBA 4 mm2; it was 1.4% in 171
patients with JBA 4-8 mm2, 3.2% in 46 patients with JBA
8-10 mm2 and 5% in 198 patients with JBA 10 mm2 (P
.001). In a Cox model with ipsilateral ischemic events
(AF, TIA or stroke) as the dependent variable, JBA (4,
4-8,8) was still significant after adjusting for other plaque
features known to be associated with increased risk (steno-
sis, GSM, presence of discrete white areas without acoustic
shadowing (DWA) indicating neovascularization, plaque
area and history of contralateral TIA or stroke. Plaque area
and gray scale median (GSM) were not significant. Using
the significant variables (stenosis, DWA, JBA and history of
contralateral TIA or stroke), this model predicted the an-
nual risk of stroke (range 0.5-10.0%). The average annual
stroke risk was 1% in 734 patients, 1-1.9% in 94, 2-3.9%
in 134, 4-5.9% in 125 and 6-10% in 34.
Conclusions: The size of JBA is linearly related to the
risk of stroke and can be used in risk stratification models.
These findings need to be confirmed in future prospective
studies or in the medical arm of randomized controlled
studies in the presence of optimal medical therapy.
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Objectives: Recently an association has been made
between Multiple Sclerosis (MS) and Chronic Cerebrospi-
nal Venous Insufficiency (CCSVI) characterized by stenosis
and reflux of the principal extracranial venous drainage
including the Internal Jugular veins (IJV) and the Azygous
veins (AZV). This is the first angiographic study to quanti-
tatively analyze the impact of percutaneous balloon angio-
plasty (PTA) on flow dynamics across these lesions.
Methods: 50 IJV formMS patients with CCSVI and 12
IJV from healthy volunteers underwent detailed angiographic
evaluation. Technical components of all venogramswere stan-
dardized. Quantitative analysis included the contrast time of
flight (TOF) from the mid IJV to the superior vena cava, and
the primary venous emptying time (PVET), quantified as
50% of venous emptying, from the IJV. The TOF and
PVET were recorded in patients with CCSVI prior and sub-
sequent to balloon angioplasty, as well in normal healthy
subjects. All data was prospectively collected, and statistical
analysis was performed using two-tailed Student’s test.
Results: Of the 50 CCSVI-MS patients with IJV ste-
nosis 70% and reflux underwent balloon angioplasty,
technical success defined as20% residual IJV stenosis was
achieved in 78% (44/50). The Table describes the pre and
post angioplasty TOF and PVET in patients with CCSVI,
as well as in healthy non-MS patients without any treat-
ment. CCSVI patients were noted to have a significant
improvement in both the TOF and PVET following bal-
loon angioplasty that paralleled healthy non-MS subjects.
Conclusions: Results of this prospective pilot study
suggest an association between MS and CCSVI, which
results in abnormally elevated TOF and PEVT through the
IJV. Furthermore, balloon angioplasty these lesions im-
proves the hemodynamic parameters that are comparable
to healthy non-MS patients.
Table.
MS patients with CCSVI
Healthy
Non-MS
Pre-
angioplasty
Post-
angioplasty
No
treatment
TOF PVET TOF PEVT TOF PEVT P value
Mean time (sec.) 5.28 12.45 2.45 6.44 2.33 6.10 .001
St. dev. 2.52 10.0 0.79 2.05 0.42 0.58
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